SingHealth Duke-NUS AM Research Institute (AMRI)

What SingHealth Duke-NUS AM Research Institute (AMRI) does

SingHealth Duke-NUS Academic Medical Research Institute (AMRI) is the research coordination arm of the SingHealth Duke-NUS Academic Medical Centre, operating within Singapore's public healthcare system as part of Singapore Health Services Pte Ltd. It coordinates clinical and translational research across 14 or more specialized research institutes covering AI in medicine, infectious diseases, precision medicine, immunology, health services research, and national disease-specific programs. The institute serves clinician-scientists, academic faculty, and internal research teams within the SingHealth Duke-NUS ecosystem, and interfaces with Singapore's national research priorities.

AMRI's core platform consists of integrated research infrastructure: clinical trials coordination, biobanking and tissue repository services, bioimaging, an ISO 13485-certified medical technology development capability, and technology transfer and incubation through the SHIP and SCOUT platforms. The ECOS platform integrates electronic consent and research workflows across the network. Disease-specific platforms including SPECTRA, Beacon (precision medicine), and ViREMiCS (infectious diseases) provide focused research environments. The institute's AI work is concentrated in the Artificial Intelligence in Medicine Institute (AIMI).

The institute operates as a non-profit public-sector research body with no commercial revenue model. Financing flows through government grants, institutional budgets from SingHealth and Duke-NUS Medical School, and partnership-based funding. The listed headcount of 7 direct staff reflects the coordinating administrative layer rather than the broader research workforce, which is distributed across the affiliated research institutes and hospital departments.

Name

SingHealth Duke-NUS AM Research Institute (AMRI)

Legal name

Singapore Health Services Pte Ltd

Website

https://research.singhealth.com.sg

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

SingHealth Duke-NUS AMRI is the research coordination arm of Singapore's SingHealth Duke-NUS Academic Medical Centre, coordinating clinical and translational research across 14+ specialized institutes serving clinician-scientists and academic teams within Singapore's public healthcare system.

Ownership category

akta.pro rank

Headquarters

HQ city

Singapore

HQ country

Singapore

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure

Distribution channels1 record

Marketing channels4 records

Core offering

AMRI is the research arm of the SingHealth Duke-NUS Academic Medical Centre, coordinating and delivering research infrastructure and core services to support academic medical research. It operates 14 joint research institutes covering AI in medicine, precision medicine, infectious diseases, translational immunology, and national disease-specific research, alongside core service platforms including the Clinical Trials Coordinating Centre (CTCC), Medical Technology Office (MTO), Investigational Medicine Unit (IMU), and SingHealth Tissue Repository (STR) for biobanking. Technology transfer and commercialization are enabled through SingHealth Intellectual Property (SHIP) and the SingHealth Technology Incubator (SCOUT).

Product overview

SingHealth Duke-NUS Academic Medical Centre operates as a platform of research institutes and core services supporting the entire healthcare research lifecycle. The portfolio includes 14 joint research institutes covering specialties from AI in medicine (AIMI) to precision medicine (PRISM), infectious diseases (IDRI), translational immunology (TII), and national disease-specific institutes (NCRIS, NDRIS, NHRIS, NNRIS). Core service platforms include the Clinical Trials Coordinating Centre (CTCC), Medical Technology Office (MTO), Investigational Medicine Unit (IMU), and SingHealth Tissue Repository (STR) for biobanking. Technology transfer is enabled through SHIP (Intellectual Property) and SCOUT (Technology Incubator). Supporting infrastructure includes the Grant Calendar, Researcher Database, and ECOS platform for study management. The Academic Medicine Research Institute (AMRI) serves as the overarching organizational structure coordinating all research activities.

Differentiator

Problem solved

Functional benefit

Products and services

• Advanced Bioimaging

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

14 partnerships are on record, tiered core.

• SingHealthcoreStrategic or Co-development PartnerSingHealth is Singapore's largest public healthcare cluster providing acute care, community care, and preventive care services. It forms one half of the SingHealth Duke-NUS Academic Medical Centre partnership with Duke-NUS Medical School.
• Duke-NUS Medical SchoolcoreStrategic or Co-development PartnerDuke-NUS Medical School is Singapore's only US-style medical school, established in 2005 as a partnership between Duke University and NUS. It forms the academic half of the SingHealth Duke-NUS Academic Medical Centre.
• Singapore General Hospital (SGH)coreStrategic or Co-development PartnerSingapore General Hospital (SGH) is the largest and oldest hospital in Singapore, serving as a major tertiary and national referral centre. It is part of the SingHealth cluster.
• National Cancer Centre Singapore (NCCS)coreStrategic or Co-development PartnerNational Cancer Centre Singapore is the national centre for cancer treatment and research, hosting the National Cancer Research Institute Singapore (NCRIS).
• National Heart Centre Singapore (NHCS)coreStrategic or Co-development PartnerNational Heart Centre Singapore is the national centre for cardiovascular care, hosting the National Heart Research Institute Singapore (NHRIS).
• National Dental Centre Singapore (NDCS)coreStrategic or Co-development PartnerNational Dental Centre Singapore is the national specialist centre for oral healthcare, hosting the National Dental Research Institute Singapore (NDRIS).
• National Neuroscience Institute (NNI)coreStrategic or Co-development PartnerNational Neuroscience Institute is the national institute for neurological and neurosurgical care, hosting the National Neuroscience Research Institute Singapore (NNRIS).
• Singapore National Eye Centre (SNEC)coreStrategic or Co-development PartnerSingapore National Eye Centre is the national specialist centre for eye care, serving as a regional centre for eye health.
• KK Women's and Children's Hospital (KKH)coreStrategic or Co-development PartnerKK Women's and Children's Hospital is the largest maternity and children's hospital in Singapore, providing specialized care for women and children.
• Changi General Hospital (CGH)coreStrategic or Co-development PartnerChangi General Hospital is an acute care hospital in eastern Singapore providing a wide range of medical services.
• Sengkang General Hospital (SKH)coreStrategic or Co-development PartnerSengkang General Hospital is a regional hospital in northeast Singapore providing general and specialist services.
• Eastern General Hospital (EGH)coreStrategic or Co-development PartnerEastern General Hospital provides acute care and community health services in eastern Singapore.
• SingHealth PolyclinicscoreStrategic or Co-development PartnerSingHealth Polyclinics provides primary care services across multiple locations in Singapore.
• SingHealth Community HospitalcoreStrategic or Co-development PartnerSingHealth Community Hospital provides community-based healthcare and rehabilitation services.

Recent moves6 records

Expansion highlights5 records

Direct peers

• Agency for Science, Technology and Research (A*STAR): Singapore's flagship public-sector R&D agency operating Biopolis research institutes in biomedical sciences, precision medicine, and clinical translation. Directly comparable as the principal competitor/parallel platform for biomedical research talent and funding in Singapore.
• Genome Institute of Singapore (GIS): A*STAR-affiliated institute conducting genomics, precision medicine, and translational research. Comparable in scientific scope (genomics, precision medicine) and Singapore public-sector research positioning to PRISM and AMRI's other specialised institutes.
• Singapore-MIT Alliance for Research and Technology (SMART): Joint MIT-Singapore research entity operating interdisciplinary research centres including biomedical and bioengineering work. Comparable as a Singapore-based, university-affiliated translational research consortium with similar discovery-to-application orientation.
• Singapore Clinical Research Institute (SCRI): Singapore-based national clinical research institute coordinating multi-centre trials and health services research. Directly comparable as a public-sector clinical research platform operating in the same Singapore ecosystem as AMRI.

Broad incumbents

• Karolinska Institutet: Swedish public-sector medical university and one of Europe's largest academic medical research organisations. Comparable as a globally renowned public medical research university coordinating multiple specialty research centres under a unified academic medical centre framework.
• Mayo Clinic Research: Large US-based academic medical centre research enterprise with multi-specialty institutes, clinical trials infrastructure, and biobanking. Comparable as a mature, integrated AMC research model with translational pipelines analogous to AMRI's structure.
• Duke-NUS Medical School: The academic partner within the SingHealth Duke-NUS AMC, with broad biomedical research and education programmes. Closely intertwined with AMRI and the de facto parent of much of its research talent pipeline; not a competitor in the traditional sense but a structural partner.

Regional players

• National University of Singapore (NUS) Research Institutes: Major Singapore public university operating multiple biomedical and life-sciences research institutes. Comparable as a parallel public-sector academic research platform competing for talent, grants, and industry partnerships within Singapore.
• Nanyang Technological University (NTU) Research Centres: Singapore public university with active biomedical engineering and life sciences research portfolio. Comparable as another Singapore-based academic research competitor for grants and translational partnerships.

Others

• National Health Innovation Centre Singapore (NHIC): Singapore's national translational and innovation funding entity supporting medtech and biotech commercialisation. Comparable as the complementary Singapore ecosystem player for technology transfer and commercial pathway development adjacent to AMRI's SHIP and SCOUT services.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Customer concentration

• YouTubeyoutube.com/@singhealthgroupresearch3355
• Facebookfacebook.com/oneamri
• LinkedInlinkedin.com/company/singhealth-dukenus-amri

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SingHealth Duke-NUS AM Research Institute (AMRI)